New blood test method under study for cancer patients
NCT ID NCT06183151
First seen Jun 02, 2026 · Last updated Jun 07, 2026 · Updated 2 times
Summary
This study involves 150 cancer patients who will provide three finger-prick blood samples alongside their routine blood draws. The goal is to see if a new testing device can accurately measure blood counts from these small samples compared to standard lab tests. The results are for research only and will not affect patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor Scott & White - Temple
Temple, Texas, 76508, United States
-
North Wales Clinical Research Facility
Wrexham, Wrexham County Borough, LL13 7YP, United Kingdom
-
Queen Margaret Hospital
Dunfermline, Fife, KY12 0SU, United Kingdom
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.